Evaluation of cost of treatment of drug-related events in a tertiary care public sector hospital in Northern India: a prospective study (original) (raw)

2009, British Journal of Clinical Pharmacology

AI-generated Abstract

Drug-related events (DREs) are a significant cause of hospital admissions, with this study evaluating the cost of treatment for DREs in a tertiary care public sector hospital in Northern India. Over four months, 92 out of 1833 admissions were related to DREs, primarily due to non-compliance, adverse drug reactions, and drug overdoses. The total cost of managing these DREs was approximately INR 17,37,339 (about €30,215), with direct costs accounting for INR 1,72,961 (about €3008) and indirect costs around INR 15,64,378 (about €27,206). In contrast, the projected cost for the same DREs in a private sector hospital was estimated at nearly four times higher at INR 63,63,872 (about €1,01,676). This study highlights the economic burden of DREs on the healthcare system and underscores the importance of patient education.